Have a personal or library account? Click to login
The effects of occupational lead exposure on selected inflammatory biomarkers Cover

The effects of occupational lead exposure on selected inflammatory biomarkers

Open Access
|Apr 2019

References

  1. 1. Shen X, Lee K, König R. Effects of heavy metal ions on resting and antigenactivated CD4(+) T cells. Toxicology 2001;169:67-80. doi: 10.1016/S0300-483X(01)00483-810.1016/S0300-483X(01)00483-8
  2. 2. Metryka E, Chibowska K, Gutowska I, Falkowska A, Kupnicka P, Barczak K, Chlubek D, Baranowska-Bosiacka I. Lead (Pb) Exposure enhances expression of factors associated with inflammation Int J Mol Sci 2018;19:1813. doi: 10.3390/ijms1906181310.3390/ijms1906181329925772603240929925772
  3. 3. Mrowicki J, Mrowicka M, Dziki A, Dziki L, Majsterek I. Etiopathogenesis of inflammatory bowel diseases. Biomark J 2018;4:8. doi: 10.21767/2472-1646.10004610.21767/2472-1646.100046
  4. 4. Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38. doi: 10.1016/j.jacc.2009.09.00910.1016/j.jacc.2009.09.009283416919942084
  5. 5. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006;47(Suppl):C7-C12. doi: 10.1016/j.jacc.2005.09.06810.1016/j.jacc.2005.09.06816631513
  6. 6. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006;86:515-81. doi: 10.1152/physrev.00024.200510.1152/physrev.00024.200516601268
  7. 7. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1976;295:369-77. doi: 10.1056/NEJM19760812295070710.1056/NEJM197608122950707819830
  8. 8. Boulay JL, O’Shea JJ, Paul WE. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 2003;19:159-63. doi: 10.1016/S1074-7613(03)00211-51293234910.1016/S1074-7613(03)00211-5
  9. 9. Navas-Acien A, Guallar E, Silbergeld E, Rothenberg SJ. Lead exposure and cardiovascular disease: a systematic review. Environ Health Perspect 2006;115:472-82. doi: 10.1289/ehp.978510.1289/ehp.9785184994817431501
  10. 10. Aoki Y, Brody DJ, Flegal KM, Fakhouri TH, Parker JD, Axelrad DA. Blood lead and other metal biomarkers as risk factors for cardiovascular disease mortality. Medicine (Baltimore) 2016;95:e2223. doi: 10.1097/MD.000000000000222310.1097/MD.0000000000002223470624926735529
  11. 11. Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med 2002;162:2443-9. doi: 10.1001/archinte.162.21.244310.1001/archinte.162.21.244312437403
  12. 12. Menke A, Muntner P, Batuman V, Silbergeld EK, Guallar E. Blood lead below 0.48 μmol/L (10 μg/dL) and mortality among US adults. Circulation 2006;114:1388-94. doi: 10.1161/CIRCULATIONAHA.106.62832110.1161/CIRCULATIONAHA.106.628321
  13. 13. Lanphear BP, Rausch S, Auinger P, Allen RW, Hornung RW. Low-level lead exposure and mortality in US adults: a population-based cohort study. Lancet Public Health 2018;3:e177-84. doi: 10.1016/S2468-2667(18)30025-210.1016/S2468-2667(18)30025-2
  14. 14. Krocova Z, Macela A, Kroca M, Hernychova L. The immunomodulatory effect(s) of lead and cadmium on the cells of immune system in vitro. Toxicol In Vitro 2000;14:33-40. doi: 10.1016/S0887-2333(99)00089-210.1016/S0887-2333(99)00089-2
  15. 15. Flohé SB, Brüggemann J, Herder C, Goebel C, Kolb H. Enhanced proinflammatory response to endotoxin after priming of macrophages with lead ions. J Leukoc Biol 2002;71:417-24. doi: 10.1189/jlb.71.3.41710.1189/jlb.71.3.417
  16. 16. Huo Y, Hafezi-Moghadam A, Ley K. Role of vascular adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesion. Circ Res 2000;87:153-9. doi: 10.1161/01.RES.87.2.15310.1161/01.RES.87.2.153
  17. 17. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connely PW, Milstone DS. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001;107:1255-62. doi: 10.1172/JCI1187110.1172/JCI11871
  18. 18. Rapisarda V, Ledda C, Ferrante M, Fiore M, Cocuzza S, Bracci M, Fenga C. Blood pressure and occupational exposure to noise and lead (Pb): A cross-sectional study. Toxicol Ind Health 2016;32:1729-36. doi : 10.1177/074823371557661610.1177/0748233715576616
  19. 19. Yücesoy B, Turhan A, Üre M, Imir T, Karakaya A. Effects of occupational lead and cadmium exposure on some immunoregulatory cytokine levels in man. Toxicology 1997;21;123:143-7. doi: 10.1016/S0300-483X(97)00107-810.1016/S0300-483X(97)00107-8
  20. 20. Machoń-Grecka A, Dobrakowski M, Kasperczyk A, Birkner E, Pryzwan T, Kasperczyk S. The effect of subacute lead exposure on selected blood inflammatory biomarkers and angiogenetic factors. J Occup Health 2018;60:369-75. doi: 10.1539/joh.2017-0307-OA10.1539/joh.2017-0307-OA617602830122729
  21. 21. Chmurzyńska A. The multigene family of fatty acid-binding proteins: function, structure and polymorphism. J Appl Genet 2006;47:39-48. doi: 10.1007/BF0319459710.1007/BF0319459716424607
  22. 22. Başar O, Akbal E, Köklü S, Tuna Y, Koçak E, Başar N, Tok D, Erbiş H, Senes M. Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis. Herz 2013;38:417-22. doi: 10.1007/s00059-012-3714-x10.1007/s00059-012-3714-x23324907
  23. 23. Beysel S, Kizilgul M, Ozbek M, Çalışkan M, Kan S, Apaydın M, Ozcelik O, Cakal E. Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease. Clin Interv Aging 2017;12:2063-8. doi: 10.2147/CIA.S13724710.2147/CIA.S137247572200629255351
  24. 24. Centers for Disease Control and Prevention (CDC). Blood Lead Levels---United States, 1999--2002. MMWR. May 27, 2005; 54(20):513-516.
  25. 25. ACGIH® Threshold Limit Values (TLVs®) and Biological Exposure Indices (BEIs®). Appendix B, 2012. [displayed 28 January 2019]. Available at https://www.nsc.org/Portals/0/Documents/facultyportal/Documents/fih-6e-appendix-b.pdf
  26. 26. Aliyev V, Kayaalti Z, Kaplan B, SoylemezogluT. Effect of GST polymorphisms on as levels of placental and maternal biological samples. Toxicol Lett 2012;211:S43-S216. doi: 10.1016/j.toxlet.2012.03.26110.1016/j.toxlet.2012.03.261
  27. 27. Valentino M, Rapisarda V, Santarelli L, Bracci M, Scorcelletti M, Di Lorenzo L, Cassano F, Soleo L. Effect of lead on the levels of some immunoregulatory cytokines in occupationally exposed workers. Hum Exp Toxicol 2007;26:551-6. doi: 10.1177/096032710707381710.1177/096032710707381717884957
  28. 28. Kasperczyk A, Dobrakowski M, Czuba ZP, Horak S, Kasperczyk S. Environmental exposure to lead induces oxidative stress and modulates the function of the antioxidant defense system and the immune system in the semen of males with normal semen profile. Toxicol Appl Pharmacol 2015;284:339-44. doi: 1016/j.taap.2015.03.00110.1016/j.taap.2015.03.00125771126
  29. 29. Karbek B, Ozbek M, Bozkurt NC, Ginis Z, Gungunes A, Unsal IO, Cakal E, Delibası T. Heart-Type Fatty Acid Binding Protein (H-FABP): Relationship with arterial ıntima-media thickness and role as diagnostic marker for atherosclerosis in patients with impaired glucose metabolism. Cardiovasc Diabetol 2011;10:37. doi: 10.1186/1475-2840-10-3710.1186/1475-2840-10-37311239121535886
  30. 30. Tanaka T, Sohmiya KI, Kitaura Y, Takeshita H, Morita H, Ohkaru Y, Asayama K, Kimura H. Clinical evaluation of point-of-care-testing of heart-type fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. J Immunoassay Immunochem 2006;27:225-38. doi: 10.1080/1532181060073491910.1080/1532181060073491916827225
  31. 31. Jeong JH, Seo JH, Ahn JY, Kim KH, Seo JY, Kim MJ, Lee HT, Park PW. The prognostic value of serum levels of heart-type fatty acid binding protein and high sensitivity C reactive protein in patients with increased levels of amino-terminal pro-B type natriuretic peptide. Ann Lab Med 2016;36:420-6. doi: 10.3343/alm.2016.36.5.42010.3343/alm.2016.36.5.420494048427374706
  32. 32. Davies MJ, Gordon JL, Gearing AJH, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM- 1, VCAM- 1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223-9. doi: 10.1002/path.171171031110.1002/path.17117103117506307
  33. 33. Nahrendorf M, Keliher E, Panizzi P, Zhang H, Hembrador S, Figueiredo JL, Aikawa E, Kelly K, Libby P, Weissleder R. 18F-4V for PET–CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging 2009;2:1213-22. doi: 10.1016/j.jcmg.2009.04.01610.1016/j.jcmg.2009.04.016277312919833312
  34. 34. Johnston-Cox HA, Koupenova M, Ravid K. A2 adenosine receptors and vascular pathologies. Arterioscler Thromb Vasc Biol 2012;32:870-8. doi: 10.1161/ATVBAHA.112.24618110.1161/ATVBAHA.112.246181575535922423039
  35. 35. Futterman LG, Lemberg L. Novel markers in the acute coronary syndrome: BNP, IL-6, PAPP-A. Am J Crit Care 2002;11:168-72. PMID: 1969064210.4037/ajcc2002.11.2.168
  36. 36. Cung H, Aragon MJ, Zychowski K, Anderson JR, Nawarskas J, Roldan C, Sood A, Qualls C, Campen MJ. Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients. J Transl Med 2015;13:99. doi: 10.1186/s12967-015-0457-510.1186/s12967-015-0457-5437634725890092
DOI: https://doi.org/10.2478/aiht-2019-70-3214 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 36 - 41
Submitted on: Oct 1, 2018
Accepted on: Mar 1, 2019
Published on: Apr 6, 2019
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Vugar Ali Turksoy, Lutfiye Tutkun, Servet Birgin Iritas, Meside Gunduzoz, Serdar Deniz, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.